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Abstract 
Problem: The most recent data from the Centers for Disease Control and Prevention (CDC, 
2018b) suggest that 130 Americans die from an opioid overdose each day, thus creating an 
unprecedented number of opioid-related deaths in the United States to date. 
Context: Of particular interest to the author and this DNP project is that Veterans are twice as 
likely to die from an opioid overdose, compared to the average American, making this epidemic 
a priority for Veterans Health Administration (Wilkie, 2018).  
Interventions: The author developed a 9-session Opioid Safety Shared Medical Appointment 
(SMA) program to reduce opioid reliance in Veterans using an 8-member interdisciplinary team. 
Comparisons were made of 90 participants who received training via Cohort I, comprised of 30 
participants led by a patient-aligned care team (PACT) that met monthly over 9 months and 
included health coaching, to Cohort II, comprised of 30 participants led by a PACT team that met 
weekly over 9 weeks and excluded health coaching, to Cohort III (control), comprised of 30 
participants who received training via routine, status quo, in-office education. The curriculum 
was based on a whole health model and introduced self-care modalities and opioid safety 
education. A comprehensive whole health toolkit was developed containing resource materials 
and educational handouts for Veterans to use throughout the course of the opioid SMA.  
Outcome Measures: Outcome measures for evaluation of this evidence-based project include 
morphine equivalent daily dose (MEDD), pain scores, and use of complementary alternative 
modalities (CAMs).  
Results: Data analysis revealed the only cohort with a statistically significant reduction in 
MEDD was Cohort I with health coaching (p < 0.0064). Cohort II (without health coaching) did 
not have a significant reduction in MEDD (p < 0.64), but did have a significant reduction in pain 
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scores (p < 0.02) and a significant increase of CAMs (p >.01). Cohort III (control group in-office 
education) did not have a significant reduction in MEDD (p < 0.88) or pain scores (p < 0.26) and 
had no significant increase in the use of CAMs (p < 0.33). However, findings of this work across 
all three cohorts included clinically significant improvements in MEDD, pain scores, and use of 
CAMs.  
Conclusions: Using whole health SMAs may provide an effective, evidenced-based, cost-
effective approach to managing chronic pain, decreasing MEDD and pain scores, and increasing 
CAM use among Veterans. While results support the clinical significance of this model, findings 
warrant additional investigation.  








The setting for this quality improvement (QI) project was the primary care (PC) 
outpatient clinic in a large tertiary Veterans Administration (VA) healthcare facility located in the 
state of Alabama, providing care for approximately 65,000 Veterans each year, with 
approximately 85,000 outpatient visits. All patients seen at the VA are adults, with a mean age of 
65.5 years.   
Opioid prescribing for the treatment and relief of chronic pain has risen precipitously 
over the last several decades, escalating the death toll of Americans dying from an opioid 
overdose to approximately 130 per day (Centers for Disease Control and Prevention [CDC], 
2018b). In 2017 alone, more than 70,000 Americans died due to drug overdoses, which included 
both illicit drugs and legally prescribed opioids (National Institute on Drug Abuse [NIDA], 
2019). The United States opioid crisis has reached critical mass, with approximately 4% of U.S. 
adults consuming opioids for chronic pain relief (Clark & Schumacher, 2017). Chronic pain has 
been reported by 50% of Veterans using the VA healthcare system (Gellad, Good, & Shulkin, 
2017).  
To illustrate the magnitude of the problem on a local level, in 2017, Alabama providers 
wrote 107.2 opioid prescriptions for every 100 persons, the highest prescribing rate in the nation, 
and almost twice the average U.S. rate of 58.7 prescriptions (NIDA, 2019). The State of Alabama 
experienced an 11% increase in death rates from opioids from 2016 to 2017 (NIDA, 2019). The 
latest available data at the facility where the study was conducted reported 12% of Veterans are 
on prescribed chronic opioids (Slack, 2018). VA patients on long-term opioids are required to 
sign an informed consent form for long-term opioid use (U.S. Department of Veterans Affairs, 
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2020). Included in the consent is information on the risks of long-term opioid use and the 
requirement for the Veteran to provide monthly urine drug screens. In the event a Veteran’s urine 
drug screen contains illegal substances, the prescriber is required to immediately address the 
safety concerns regarding mixing illegal opioids with prescribed opioids. This change of practice 
DNP project was selected because healthcare teams and individual clinicians have been seeking 
solutions to end the opioid crisis, with limited success.    
  Although the national focus has been placed on identifying the cause of the opioid 
epidemic, little success has been achieved at developing a comprehensive approach to reducing 
reliance on powerful and addictive pain medications. Looking at the magnitude of this crisis, in 
2017, illicit and prescribed opioids were responsible for 47,600 overdose deaths in the United 
States, 67.8% of all overdose deaths (CDC, 2017). Opioids have now surpassed firearms as the 
leading cause of accidental deaths in the United States (Siegel, 2018). Furthermore, Dasgupta, 
Beletsky, and Ciccarone (2018) reported that the United States and Canada lead the world in the 
highest per capita opioid consumption, with 41% of overdoses occurring in urban counties, 26% 
occurring in the suburbs, 18% occurring in small metropolitan areas, and 15% occurring in rural 
areas. In 2017 alone, an estimated 17.4% of the U.S. population was prescribed one or more 
opioids, with the average person receiving 3.4 prescriptions (CDC, 2018a). This evidence 
highlights the urgent need for a solution to the unacceptable opioid crisis facing our nation. 
Earlier methods to address the opioid crisis, such as forced reductions, have been found 
to produce counteractive and unsafe results, necessitating alternative approaches to decrease 
opioid reliance (Joseph, 2019). Much debate and blame have transpired regarding how our nation 
ended up in an opioid crisis. To date, sustainable approaches to effectively reduce opioid reliance 
remain elusive. 
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To move toward a safer and patient-centered approach to reduce opioid reliance and 
improve the patients’ quality of care, an interdisciplinary team brought together two emerging 
and effective modes of care. The whole health model was used within the context of a shared 
medical appointment (SMA) with a group of Veterans derived from a single provider’s panel of 
patients. An SMA is a medical appointment where patients are seen by clinical staff in a group 
setting that combines education and discussion regarding self-management of a chronic 
condition or disease (Omogbai & Milner, 2018). The SMAs were 90-minute appointments and 




Melnyk, Ford, and Overholt’s (2017) intervention template was used to develop the 
following population, intervention, comparison, outcome, time (PICOT) question for this change 
of practice DNP project: (P) For Veterans reliant on opioids, (I) what is the effect of shared 
medical appointments, with a full patient-aligned care team using a whole-person health 
approach and health coaching on opioid usage, pain scores, and use of complementary 
alternative modalities, (C) compared to education via office visits (T) over 12 months?  
Search Methodology 
The literature review to support this project was conducted from February 2019 to March 
2020. To ensure the strongest and most relevant evidence, 90 articles were reviewed using the 
Johns Hopkins Nursing Evidence-Based Practice Guidelines and scoring system (Dang & 
Dearholt, 2018). This tool appraised the strength and quality of evidence found in each study and 
helped determine the inclusion and exclusion criteria for addressing the author’s evidence-based 
practice question. The inclusion criteria included full-text articles, published in English, from 
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2014 to 2019. The search yielded 15 studies, which included research, non-research, and 
supportive studies (one editorial) that provided statistics and evidence on the opioid crisis. The 
articles were chosen based on their relevance to the QI topic and the strength of their evidence. 
To gain the strongest evidence, multiple databases were searched and included the Cochrane 
Library, PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL) 
databases and evidenced-based journals. The search used the following keywords: opioids, 
reliance, whole health, group appointments, and Veterans. Inclusion criteria included articles 
from 2005 to 2020 from peer-reviewed journals and published in the United States. Exclusion 
criteria included book chapters and articles outside the United States.  
Summary of Evidence 
After reviewing the abstracts, 73 articles were excluded that failed to align with the 
study’s scope and relevance. The final literature selection criteria were determined after 
reviewing the strength, weaknesses, limitations, and quality of the evidence; 15 articles 
demonstrated the best possible evidence upon which this intervention was based. The search 
resulted in four Level II A/B, seven Level III A/B, one Level IV A/B, and three Level V,  A 
studies. The search revealed a noticeable gap in the literature pertaining to the use of a whole 
health approach and SMAs to address the opioid crisis or to decrease opioid usage in the Veteran 
population.  Therefore, most articles were qualitative and geared toward QI initiatives and 
statistical data regarding the opioid crisis. A summary of results from the appraised evidence is 
included in an evaluation table (see Appendix A). Three themes emerged from the summary of 
evidence in the review of articles and research studies: (a) impact of the opioid crisis, (b) use of 
SMAs in clinical settings, and (c) past approaches and modalities to address the opioid crisis. 
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Impact of the opioid crisis. From 1999 to 2014, nearly 400,000 Americans died from an 
opioid overdose, including prescription and illicit opioids (CDC, 2017). The estimated total 
economic burden of prescription opioid misuse in our nation has skyrocketed to $78.5 billion 
annually, which includes the cost of healthcare, addiction treatment, lost productivity, and 
criminal justice involvement (CDC, 2017). The following review of the literature depicts the 
extent of the opioid crisis and genesis of the crisis. 
Tyndale and Sellers (2018), nationally recognized experts, opined based on experiential 
evidence that prescription opioid sales in the United States nearly quadrupled from 1999 to 2014, 
without a significant change in the amount of pain reported by Americans. The United States is 
the leading nation for the highest rate of opioid prescribing. The rapid rise in opioid overdose 
death rates in the United States was driven by three separate waves of lethal drugs. The first 
wave of prescription opioid mortality started in the late 1990s, followed by a second wave of 
deaths from heroin starting in 2010, culminating in the current third wave of deaths due to 
synthetic opioids, which include illicit fentanyl and fentanyl analogs (Tyndale & Sellers, 2018). 
Tyndale and Sellers point to the urgent need for more leadership and funding to find an 
evidence-based solution to the opioid crisis. 
In an integrative review conducted by Chen, Shiels, Thomas, Freedman, and Berrington 
(2018), a comparative analysis of data from 13 countries of premature mortality from drug 
overdoses was reviewed. Using the World Health Organization’s mortality database to collect 
the yearly number of deaths due to drug overdoses, the search was limited to adults aged 20 to 
64. Findings indicated the U.S. opioid overdose death rates were more than twice the number of 
those in any other country. Overdose death rates were highest for men in the 35- to 49-year age 
group and for women ages 50 to 64 years. Drug overdose deaths more than doubled in the 21st 
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century, with an estimated 63,632 deaths in 2016. This study’s limitations included restrictions to 
those countries with the highest quality data, differences in coding practices, and the inability to 
compare the contributions of specific drugs to mortality death rates of each country (Chen et al., 
2018).  
To further illustrate the magnitude of the problem, New Jersey’s Governor Christie led a 
commission to assist the President in developing recommendations to combat the opioid crisis, to 
include a national curriculum to educate prescribers on standards of care for administering 
opioids. Through subject matter expert interviews and testimonies, the governmental consensus 
panel determined that a multi-pronged approach is needed to address our nation’s opioid crisis. 
Mental health services in our nation are lacking, as only 10.6% of youth and adults in the United 
States who need treatment for opioid addiction are receiving it (Christie et al., 2017). 
Recommendation strategies to reduce the opioid supply of illegal drugs into the United States 
include improved collaboration and information sharing between law enforcement agencies to 
target the supply chains (Christie et al., 2017). The illegal entry of opioids into our nation has 
contributed to the overall crisis and must be addressed. The commission’s recommendations 
apply to both the Veteran and non-Veteran population who consume illegal opioids and supports 
the use of an interdisciplinary whole health approach to combat the opioid crisis.  
To highlight the extent of the opioid crisis, Han et al. (2017) discussed findings from the 
National Survey on Drug Use and Health of non-institutionalized American adults (n =51,200) 
who reported opioid use. The purpose of this labor-intensive, in-person, qualitative study, 
conducted by the Substance Abuse Mental Health Services Administration, was to measure 
prescription opioid use, misuse, use disorders and motivation for use.  Survey results revealed 
that 37.8% of U.S adults used prescribed opioids, 4.7% misused opioids, and 0.8% had an opioid 
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use disorder. The purpose of this study was to link use disorders to economic and behavioral 
health issues, as misuse was most commonly reported in high-risk individuals, such as the 
uninsured, unemployed, low income, or those with a mental health history (Han et al., 2017). As 
discussed previously, Veterans are included in this at-risk population.  
Edmond et al. (2018) conducted a cross-sectional survey (n = 460) over 12 months to 
examine rates and correlations of non-pharmacological modalities (NPMs) use in Veterans 
during recent Middle Eastern conflicts. This qualitative study’s findings  with meta-synthesis 
included 43.7% of male Veterans and 56.3 % of female Veterans who had received care in PC 
settings reported chronic pain. Most Veterans reported using a minimum of one NPM within the 
past 12 months of the survey. A major limitation of this study was the lack of measurement of 
the effect of the NPM on Veteran pain levels. This study’s findings can be used to tailor pain 
management strategies using NPM of the patient’s choice.  
Nahin (2018) conducted a qualitative study of data extracted between 2010 and 2014 
from the National Health Interview Survey (NHIS) Sample Core and the NHIS Adult 
Functioning and Disability Supplement. This labor-intensive survey (n = 67,696) compared pain 
levels in a population of Veterans (n = 6,647) and non-Veterans (n = 61,049). Survey 
participants with severe pain were identified by a validated pain severity system that was part of 
the NHIS Adult Functioning and Disability Supplement. Veterans are generally considered 
healthier than the average citizen upon entering active duty due to the rigorous physical and 
mental health screening requirements to join the service. While serving, active duty military are 
considered high risk for combat and non-combat related injuries and are frequently exposed to 
both environmental and mental stressors. Results revealed that more Veterans (65.6%) than non-
Veterans (56.4%) reported pain in the three months before the time of the survey. The percentage 
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of severe pain was also higher in Veterans (9.1%) versus non-Veterans (6.3%), particularly those 
who had served in recent military conflicts. The study findings did not link specific causes for 
increased pain levels in Veterans compared to non-Veterans and did not offer a risk-mitigating 
strategy for the Department of Defense consideration. The study findings reflect the need for 
revised pain management strategies in the outpatient setting, especially for the Veteran 
population.  
Although most of the information reviewed by the author regarding the impact of the 
opioid crisis was found in recommendations, qualitative studies, and QI studies, the data 
supported an immediate need to find a solution to the opioid crisis in the Veteran population. 
SMAs in clinical settings. In a prospective study, Romanelli, Dolginsky, Byakina, 
Bronstein, and Wilson (2017) demonstrated the benefit of SMAs for addressing various chronic 
medical conditions, including chronic pain. Survey data from 130 patients who attended SMAs 
showed improvements in patients’ confidence levels to manage their pain and their healthcare 
team’s ability to assist them in managing their pain. Overall, satisfaction with attending the SMA 
was 81%. The authors discussed the positive impact SMAs have on improving patient 
satisfaction, increasing connectivity with the clinical care team, resiliency, and facilitating care 
coordination. This study reflects the value of SMAs in promoting opioid safety and awareness, 
along with shared decision-making with the patient’s healthcare team. Romanelli et al. noted that 
the use of SMAs in PC clinic settings increases however, a standardized approach to 
implementing SMAs is needed and supports this change of practice DNP project. 
Several studies evaluated the impact of SMAs on patients with diabetes. The strongest 
evidence to support practice changes in the use of SMAs was found in work done by Drake, 
Meade, Hull, Price, and Snyderman (2018). Their quasi-experimental study reviewed survey data 
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(n = 12) from Type II diabetes mellitus patients who attended eight SMAs over seven months. 
The study reviewed the feasibility of incorporating personalized health planning into SMAs and 
collected qualitative data from focus groups, patients, and clinical staff. Clinical outcomes 
included reductions in hemoglobin A1C, low density lipoprotein, body mass index, blood 
pressure and an increase in achievement of health goals. The use of personalized health planning 
in SMAs in the clinical setting shows great promise in helping the patient and healthcare team 
identify health goals and plan a delivery of care that is patient-centered.   
In a QI study by Omogbai and Milner (2018), SMAs were launched for a group of 
Veterans with diabetes. The VA reported the diabetic population to be at 24%, compared to the 
national average of 9%. This qualitative study involved male Veterans (n = 30), with a mean age 
of 64.7 years (SD = 5.36), who attended an SMA from October 15, 2015, to March 15, 2016. The 
following clinical data points were assessed: A1C, blood pressure, total cholesterol, HDL, LDL, 
triglycerides, body mass index, and VA hospitalizations. At the end of the SMA, a decrease was 
observed across the three data points of blood pressure, total cholesterol, and triglycerides, with 
only minimal changes in the mean HDL levels. This study supports the use of SMAs to impact 
clinical outcomes positively. 
In a systematic review of 17 randomized control trials and nonrandomized cluster-
controlled trials, Edelman et al. (2012) found significant improvements in patients’ clinical 
outcomes after attending SMAs; outcomes included hemoglobin A1C (-0.55 percentage points 
{95% CI, -0.11 to -0.99} and improved systolic blood pressure (-5.2 mmHg {95% CI, -3.0 to -
7.4}; however, there was not an improvement in low density lipoprotein cholesterol (-6.6 mg/dl 
{95% CI, 2.8 to 16.1}. This study indicates that SMAs can be a useful approach to impact 
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clinical outcomes among patients with diabetes and supports their use for other clinical 
conditions. 
In a pre-post cohort, QI study at two VA facilities with PC clinics, Cain et al. (2017) 
sought to improve hypertensive VA patients’ (n = 21) access and quality of care through their 
participation in pharmacist-led SMAs. The aim was to decrease blood pressure and improve 
medication adherence for those Veterans attending a pharmacist-led SMA. The study’s findings  
showed that the Veterans who attended a pharmacist-led SMA had significant reductions in 
systolic blood pressure; however, the medication adherence did not change significantly from 
baseline. This study suggests a strong linkage between education in group settings over 
individual office appointment education. SMAs could easily be replicated for various other 
health conditions in other healthcare settings.   
 Wadsworth et al. (2019) conducted a systematic review without meta-analysis of 1,359 
papers, qualitative studies, and quantitative studies, comparing outcomes from patients who 
attended SMAs versus those who had received in-office visits. Overall results indicated positive 
patient-provider qualitative advantages over in-office visits to include improved communication 
time with their provider. Wadsworth et al. noted that patients reported being more satisfied with 
their care after attending SMAs versus the care they received during in-office visits in multiple 
qualitative studies. Patients perceived providers were less hurried during SMAs than in regular 
office visits. The authors pointed out that the use of SMAs is increasing in popularity in primary 
care settings, yet a gold standard for conducting an SMA does not yet exist, which supports the 
need for further study. 
 Each of the above studies using SMAs positively impacted the participants’ health 
outcomes and supports the use of SMAs in decreasing opioid reliance in the Veteran population. 
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Past approaches and alternative modalities. Nationally, numerous approaches to 
combating the opioid crisis have been explored. Complementary and alternative modalities 
(CAMs) exist to assist individuals reliant on opioids to find alternatives to taking opioids for pain 
relief. CAMs, such as mindfulness, acupuncture, tai chi, and meditation, help provide patient-
centered treatments and present palatable alternatives for the patient reliant on chronic pain 
medications.   
 In a qualitative factor analysis observational study, Betthauser et al. (2014) reviewed 
interviews and surveys from Veterans (n = 97) at a VA facility to assess their acceptability of 
CAM, conventional medicine, mind-body integration, and belief in CAM. Previous Veteran-
focused studies found that 23% to 50% of Veterans utilize some form of CAM, and those not 
currently using CAM would be open to using a CAM, if it was made available to them. Findings 
from this study included the Veterans’ acceptability for using CAMs as an effective means to 
maintain health. Veterans who reported current CAM use endorsed the following modalities: 
spirituality/prayer (39%), meditation/yoga/relaxation/imagery (21%), herbal/botanical 
supplements (19%), and dietary (19%). The most frequently used CAM was massage, at 61%. 
This study underlines the importance of assessing Veterans’ willingness to explore CAM options 
as alternatives to pain medications. 
 In a systematic scoping review with meta-analysis, Rani, Johnston, Bormann, Hull, and 
Taylor (2014) reviewed the literature from 1976 to 2014 to determine the Veterans and active 
duty personnel’s mind-body practices to determine gaps in the literature regarding CAM usage in 
this population. The most observed practices were meditation (n = 25), relaxation exercises with 
imagery (n = 20), physical therapy and spinal manipulation (n = 16), and acupuncture (n = 11). 
Recommendations were made for further research on the most frequently used CAMs to improve 
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Veterans and active duty personnel’s health. These findings support the effectiveness of CAMs 
for Veterans and active duty personnel in developing whole health treatment plans in the PC 
setting.  
 Frank et al (2017), in a systematic review with randomized control trials with meta-
analysis, synthesized the effectiveness of methods to decrease long-term opioid therapy (LTOT) 
for chronic pain in U.S. adults. The patient outcomes assessed were the severity of pain, quality 
of life, function, withdrawal symptoms, substance abuse, and adverse events. Findings included 
that pain levels and quality of life functions may improve  both during and after opioid reduction. 
Data synthesis was completed of 67 studies, including 11 randomized control trials and 56 
observational studies. Opioid tapering was reported as challenging for both the clinician and the 
patient, with routine discontinuation ranging between 8% to 35%. In one survey of patients on 
LTOT, approximately 50% of patients verbalized a desire to cut down or discontinue their opioid 
use; however, 80% were still being prescribed high-dose opioids one year later. In patients who 
had a non-fatal opioid overdose, 91% remained on opioids after the overdose. Little evidence 
exists to help clinicians safely guide patients through the process of tapering off LTOT, 
especially in the PC setting, where the majority of LTOT is prescribed. Care provided by 
multidisciplinary teams, along with close follow-up, was noted as positive attributes of programs 
evaluated in this study. This systematic review underscores the importance of physicians 
discussing the risks and benefits of tapering LTOT and referring patients to multidisciplinary 
pain teams for additional support while decreasing their usage of opioids.  
In synthesizing the evidence from literature review, no single approach emerged related 
to using a whole health approach to decrease opioid reliance. However, the positive patient 
outcomes that occurred with past diabetes mellitus and hypertension SMAs support the need for 
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immediate practice change for implementation in the PC setting to reduce opioid usage. The 
literature review clearly depicted the medical, financial, and psychological impact of opioid 
reliance and supported finding a risk mitigating approach. Additionally, the evidence 
demonstrates that SMAs are superior over in-office education. The author found it remarkable 
that literature review yielded zero evidence of past practices for using SMAs to reduce opioid 
reliance. Although literature review added significant value to the body of evidence regarding the 
opioid crisis and causative factors, further study is needed to fill the gap between identification 
of the problem of opioid reliance and the solution for a practical, cost-effective, and sustainable 
approach for managing chronic pain. 
Rationale 
Two theoretical frameworks heavily influenced the development and interpretation of this 
project, including Pender’s (2011) health promotion model (HPM) and the VA’s proactive health 
and well-being model (Gaudet & Kligler, 2018).   
Pender’s Health Promotion Model 
A commonly used behavioral change model, Pender’s (2011) HPM uses social cognitive 
theory and its factors (perceived strengths, barriers, self-efficacy) to influence engagement in 
health promoting behaviors, such as reducing reliance on opioids. The model assumes that 
individual differences (i.e., demographics, personality), interpersonal influences, and behavioral 
and environmental factors interact with each other to influence the cognitive, motivational 
processes requisite for behavior change. Five core concepts, including person, environment, 
nursing, health, and illness, comprise the model and provide rich sources of interventional 
content and strategies, including specific, measurable, achievable, realistic, and timely (SMART) 
goal setting. The use of SMART goals proved to be an integral component of this DNP project. 
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 The concept of self-efficacy—a person’s belief in his/her capacity to execute behaviors 
needed to produce specific performance attainments (Bandura, 2013)—also heavily influenced 
this project, secondary to its temporal implications for behavioral change. For example, 
developing self-efficacy requires reinforcement (i.e., behavioral feedback) for approximated 
behavior over time (Bandura, 2013). Over iterations of positive behavioral feedback (i.e., 
positive or negative reinforcement) for applying new information/knowledge, self-efficacy grows 
as behavior improves, and behavior improves as self-efficacy increases. This behavioral process 
resulted in the team’s decision to change the frequency of SMAs from monthly to weekly.  
The HPM model was chosen for this DNP project as each of the principles, including 
self-efficacy, aligned with the SMA opioid safety program’s whole health concepts. 
Additionally, the concepts guided each phase of this QI study by focusing on how they are 
interrelated to achieve optimal health by selecting healthy behaviors. Pender’s (2011) HPM had 
applicability in the development, implementation, and aim of this QI study.  
Veterans Administration’s Proactive Health and Well-Being Whole Model 
Also with origins in health promotion theory, the second theoretical framework used in 
this QI project was the VA’s Proactive and Well-Being Model (see Appendix B), which outlines 
the eight dimensions of health and served as the underpinning for this QI project (Simmons, 
Drake, Gaudet, & Snyderman, 2016). This model moves beyond the traditional disease model, 
which centers on “What’s the matter?” to a broader question of “What matters most?” (Gaudet & 
Kligler, 2019). These alternative conversations with Veterans with chronic pain help healthcare 
staff gain a broader view of how pain interferes with patients’ goals. At this juncture, the 
healthcare team can truly begin to partner with the Veterans in helping them connect how their 
present behaviors may be working against them in achieving their whole health goals.  
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Gaudet and Kligler (2019) discussed the 15-year history of integrating a new paradigm of 
whole health in the VA. The VA’s Office of Patient-Centered Care and Cultural Transformation 
(OPCC & CT) researched and evaluated this transformation from the usual endpoints of reduced 
indications of disease to the measurement and collection of well-being outcomes. According to 
Gaudet and Kligler, to achieve this major change, the VA system has adopted a whole health 
strategy, which includes addressing practices of the Veteran, their family, and the community, 
along with social determinants. The authors stressed the importance of assessing specific 
outcome data to determine when a true transformation has occurred related to the Veterans’ 
health and well-being. Through motivational interviewing and shared goal setting, the healthcare 
team can assist the Veteran set SMART goals directed at facilitating movement toward the 
Veteran’s unique mission, aspiration, and purpose (Gaudet & Kligler, 2019).  
In this study, health coaching and facilitation of shared SMART goals, within the SMA 
confines, assisted Veterans in addressing a broader array of health and life issues and potentially 
improving their quality of life and reliance on opioids. The whole health model was chosen for 
this DNP project based on its direct applicability in the SMA curriculum development and 
implementation. 
Specific Aim 
 This change of practice DNP project was completed in September 2020. This QI study’s 
specific purpose was to assess the impact of SMAs on morphine equivalent daily dose (MEDD), 
pain scores, and use of CAMs for managing pain. SMAs were used to introduce concepts of self-
care, opioid safety education, and goal setting.   
AIM Statement 
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 The overarching aim of this project included: By September 2020, 30 Veterans at the VA 
project site who participated in a 9-month whole health opioid safety SMA led by patient-aligned 
care team (PACT) staff to include a health coaching component, will have a 10% or greater 
decrease in the MEDD, decreased pain scores, and a 10% increase in the use of CAMs for pain 
management. This will be compared to 30 patients who participated in a 9-week whole health 
opioid safety SMA led by PACT staff without health coaching, compared to 30 Veterans who 
received standard, in-office education. An outline for the course curriculum delineates the 
differences between the composition of the three cohorts (see Appendix C). 




A whole health SMA opioid safety program was developed to assist Veterans decrease 
their MEDD and pain scores and increase their use of CAMs. This QI study was launched at a 
tertiary outpatient VA healthcare facility in the southern United States to answer our nation’s call 
to assist Veterans decrease their opioid reliance. A 9-week opioid safety program was 
implemented, comprised of 90-minute weekly appointments, known as SMAs, using a whole 
health framework. SMAs are also referred to as group appointments, which combine a medical 
appointment with education and discussion regarding self-management of a chronic condition or 
disease (Omogbai & Milner, 2018). The SMA was designed as a single, 90-minute appointment. 
Each SMA began with obtaining verbal consent from each Veteran.  
 Stakeholders. A stakeholder analysis was conducted to prioritize the top four 
stakeholders involved in implementing this DNP project: Veterans on chronic opioids at a large 
urban VA, PC teams at the VA, external PC teams, and the project site’s executive leadership 
team (ELT). The author believes the most likely element at the project site that influenced and 
supported this DNP project was stakeholder awareness of the urgent need to find a solution to 
ending the opioid crisis among Veterans. Each stakeholder group was aware and open to the need 
for change from the status quo opioid safety education delivery mode. Specific considerations for 
each group are described below. 
                 Veterans. For Veterans on chronic opioids at the project site, the major perspectives 
included the Veterans’ anticipation and excitement of finding an approach to choose how to 
reduce their reliance on opioids, while still managing their pain. The Veterans’ perspectives were 
key to program implementation, as without their voluntary participation, belief in the program, 
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and ability to make behavior changes, the program would have failed. An added advantage of the 
innovation was the pre-established connectivity between the Veteran and their PC team who 
conducted the SMAs. The Veterans’ agreement to participate in this voluntary program was a 
testament to their vested interest in making behavior changes, such as reducing their opioid 
reliance and reflecting the shared decision-making power between themselves and their PC team. 
The group of stakeholders’ strategic approach included partnering with their PC team to 
determine alternative modalities to control their pain.  
                  Internal Primary Care Teams. The major perspectives of PC teams at the project site 
included excitement about the possibility of implementing the same approach as their co-workers 
in finding an alternative approach to decreasing their Veterans’ reliance on opioids, while still 
managing their pain. To connect with this group of stakeholders, patient-care outcomes and 
program successes of prior SMAs conducted by PC teams they work with were shared to build 
enthusiasm and to gain potential participation in the program. To further connect with this group 
of stakeholders, they were provided the opportunity to attend a 3-day opioid safety mini-
residency provided by the implementation team to gain insight into running their SMA, which 
included in-depth instructions, lessons learned, and resources to begin their program. The type of 
power for this group of stakeholders was one of shared power, in that the program empowered 
them to meet a need they had to assist their Veterans decrease opioid reliance. The project site’s 
PC teams’ strategic approach was to partner with PC teams they knew had an innovative 
approach that produced promising outcomes in opioid reduction using whole health concepts. 
                 External primary care teams. The external PC team stakeholders’ major perspectives  
included their interest and curiosity regarding what the VA had implemented that could assist 
their patients to decrease their reliance on opioids, while still managing their pain. The 
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participation of external PC teams in the program was instrumental in program spread and has 
the potential to answer our nation’s call to end the opioid crisis. Connections were made with this 
group of stakeholders, to include poster presentations, public presentations, journal articles, and 
publications, including the American Hospital Association’s Opioid Stewardship Implementation 
Guide. Additionally, this group of stakeholders was provided the opportunity to attend a 3-day 
opioid safety mini-residency provided by the implementation team to gain insight into how to 
run their SMA, includjng in-depth instructions, lessons learned, and resources to begin their 
program. Like the project site’s PC teams, external PC stakeholders held shared power, in that 
the program offered to meet a need they had to assist their Veterans decrease opioid reliance. The 
strategic approach of external PC teams was to partner with the implementation team to learn 
about the innovative approach that produced promising outcomes in opioid reductions using 
whole health concepts. 
                 Executive leadership team. The major perspectives of the project site’s ELT 
stakeholders included their willingness to provide their support in terms of resources and 
encouragement for making this innovation successful. Their ongoing support from day one was 
key to program implementation to align time and resources for both conducting SMAs and mini-
residencies. To connect with this group of stakeholders and garner ongoing program support, 
frequent briefings were given to share program outcomes and successes. The implementation 
team recently participated in a video highlighting the team’s work with reducing opioid reliance 
in the Veteran population, as an example of work being accomplished to become a high 
reliability organization. The project site’s ELT held positional power over the implementation 
team. The group of stakeholders’ strategic approach was to provide ongoing support of the 
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needed resources of time, space, and personnel to continue this successful, innovative program in 
helping Veterans and other Americans reduce their opioid reliance. 
After prioritizing the project’s stakeholders, a power analysis (Grace, 2017) versus 
interest review was completed to categorize each group based on their power and interest over 
this project. The Veterans and ELT stakeholders were categorized as high power, high interest, 
indicating they needed to be managed closely, with the greatest efforts to satisfy them. The 
project site’s PC teams and external PC teams were categorized as low power, high interest, 
indicating they needed to be kept informed and communicated with often to ensure no major 
issues were experienced.   
Future plans to influence the VA culture and external healthcare systems to make it open 
and receptive include promoting the ease of program implementation, sharing our team’s 
expertise and resources by invitation to participate in a mini-residency, and sharing the outcomes 
and successes of prior SMAs. 
Interventions 
 The author held primary responsibility for all portions of this DNP change of practice 
project, which took place between February 2019 and December 2020. The author worked 
closely with an interdisciplinary team at the project site, to include the PC physician and 
pharmacist who managed the participants MEDD throughout the project. 
            Shared medical appointments. The first intervention chosen by the author for this project 
was to evaluate outcomes from Veterans who attended opioid safety SMAs, consisting of nine 
sessions led by two different PACTs, compared to outcomes from Veterans receiving the status 
quo, in-office education only. This evidence-based intervention was chosen to determine the 
clinical efficacy and impact of delivering opioid safety education via SMAs over traditional in-
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office education. Healthcare staff involved in this project came from different backgrounds, held 
different beliefs, and were racially diverse.  
The original SMAs were led by Cohort I, comprised of a complete PACT, including a 
physician, registered nurse (RN), licensed practical nurse (LPN), and medical service assistant 
(MSA). The facilitator coordinated the SMAs, secured the meeting location, facilitated the data 
collection tools, and determined topics for the each SMAs’ education portion. Additional 
interdisciplinary staff (dietician, social worker, psychologist, pharmacist) were consulted and 
used as subject matter experts throughout the SMA course. Cohort I met monthly over a 9-month 
period and included health coaching as part of their curriculum to assist the Veterans formulate 
SMART whole health goals. Cohort II was led by a complete PACT who met weekly over a 9-
week period and did not include health coaching. Both Cohort I and Cohort II followed a 
curriculum based on the whole health model and included opioid safety education during each 
session. Intermittent education was also provided to Cohort I and Cohort II in specific areas 
related to self-care by interdisciplinary staff. Didactic teaching sessions, utilizing multimedia and 
short training videos, were used by Cohort I and Cohort II to promote discussion and self-
reflection. Educational materials were provided to both cohorts by the VA’s OPCC & CT, 
including the Wheel of Health and eight dimensions of self-care. Integrative healing modalities 
were introduced during the SMAs, such as mindfulness, tai chi, yoga, and physical therapy. 
Cohort III was comprised of 30 Veterans receiving in-office, status quo opioid safety education 
over nine months by the provider, without a full PACT, health coaching, or educational materials, 
or the use of a whole health curriculum.  
            Toolkit.   The second intervention included developing a whole health comprehensive 
toolkit containing resource materials and educational handouts for Veterans to use throughout the 
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opioid safety SMA. The author chose the toolkit based on the need to consolidate handouts and 
educational materials to guide Veterans through each SMA session and provide a standardized 
approach for other PACTs to use. A copy of the toolkit index is included as Appendix D. The 
toolkit was comprised of materials supplied by the VA’s OPCC & CT, along with educational 
materials prepared by subject matter experts for in-class instruction. For example, the content 
included agendas for each class, ground rules, and listings of additional resources for participants 
to access, such as video links for tai chi and yoga demonstrations. The toolkit was posted on the 
project site’s SharePoint and made accessible for other teams to conduct SMAs.   
Gap Analysis 
The desired state of finding a safe and effective approach to decreasing opioid usage in 
the Veteran population is clearly supported in the literature. The VA’s current approach for 
decreasing Veterans’ chronic use of opioids includes adherence to a four-pronged strategy that 
includes education, pain management, addiction and treatment, and risk mitigation (Gellad et al., 
2017). However, a review of the literature identified a noticeable gap between the VA’s strategy 
to address the opioid crisis affecting the Veteran population and a patient-centered whole health 
(holistic) approach to reducing usage, while managing pain (see Appendix E). To address the 
gap, specific interventions were put into place, including developing and implementing a nine-
session whole health curriculum of SMAs on opioid safety in PC clinics at the author’s site. Each 
session included a component on opioid safety and focused on one of eight dimensions of whole 
health.  
The sessions for Cohort I were conducted over nine months and included a health 
coaching component. The author served as the facilitator for Cohort I and coordinated various 
whole health educational topics presented by interdisciplinary subject matter experts. The 
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sessions for Cohort II were conducted over nine weeks, but did not include a health coaching 
component. A facilitator coordinated various whole health educational topics presented by 
interdisciplinary subject matter experts. The control group, Cohort III, did not include health 
coaching, did not use a facilitator, and did not use interdisciplinary subject matter experts to 
provide whole health education. 
Gantt Chart 
The DNP project took place from January 2019 to December 2020. A Gantt chart is 
provided to illustrate the project’s milestones (see Appendix F). The author’s original Gantt 
chart, developed in the first semester of the DNP program for this QI project, changed after 
receiving internal feedback. The original project’s topic  was aimed toward the development of a 
staff toolkit for future teams to use for launching their own SMAs. After consultation with the 
DNP’s chairperson, the author changed the QI project course to include comparing clinical 
outcomes from three groups of Veterans. The Gantt chart depicted activities from the start of the 
project through completion, to include required coursework needed for graduation.  Milestones 
included planning, implementation, evaluation, and closeout phases of the project. 
Assessment and problem identification. The assessment and problem identification 
phase was initiated in February 2019 and included developing the PICOT question and Aim 
Statement. The evidence-based literature review regarding the impact of the opioid crisis, SMAs 
in clinical settings, and past approaches and modalities was completed in October 2019. It 
formed the basis of this change of practice DNP project. 
Planning. The planning phase took place from June 2019 through October 2020 and 
included retrospective record reviews of 90 participants in three cohorts in this study. 
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Additionally, a toolkit for Veteran use during opioid safety SMAs was finalized during this 
phase of the project.  
 Implementation. The implementation phase took place from November 2019 through 
July 2020. It included analyzing extracted data, interpreting findings, and formulating 
assumptions from data collected from 90 medical records of participants involved in this project.  
During this phase, a SharePoint site was created comprised of educational materials and slide 
presentations that could be used to conduct opioid safety SMAs locally and at other VA 
facilities. 
Evaluation. The project evaluation began in August 2020 with data analysis and 
synthesis of project findings and submission of the final DNP project concludes December 2020 
with the final DNP project presentation. 
Work Breakdown Structure 
This project involved evaluating the effectiveness of whole health opioid safety SMAs 
for Veterans reliant on opioids at the project site. A top-down approach of the work breakdown 
structure (WBS) was used to execute the objectives of this change of practice DNP project by 
graphically displaying the increments of work into individual steps to ensure all tasks aligned 
with the proposed timeline and priorities in the project (see Appendix G). The approach selected 
to conduct the WBS was based on the nursing process, including assessment and problem 
identification, planning, implementation, and evaluation. The author identified the tasks early 
since formulating the four phases of the WBS were continued through to the full implementation 
of the project. The WBS fit well into the VA culture and served as an effective means to track 
and trend progress from start to completion.     
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In preparation for constructing the WBS, a meeting was conducted with the on-site 
mentor to determine the project’s scope, implementation, and associated costs. The WBS was 
key to the successful completion, launch of interdisciplinary use, and enterprise-wide 
dissemination of SMAs for a whole health approach for Veterans to choose sustainable and 
effective non-medication alternatives for chronic pain. The potential for sustainable lifestyle 
changes for Veterans reliant on opioids for pain management is extremely important and relevant 
to our nation,  individuals, and communities during this crisis. 
 Strength, Weaknesses, Opportunities, and Threats (SWOT) Analysis 
The interventions in this project were analyzed using a SWOT analysis (see Appendix 
H).  
            Strengths. This program’s identified critical strength was the baseline outcome data 
collected by the original SMA team, which revealed promising results. The SMA built 
comraderie, a sense of community, and accountability and empowered Veterans to decide how to 
manage their pain based on their preferences and goals. An additional strength of this program 
included the program’s whole health foundation, where the Veteran oversaw all healthcare 
decisions made about him or her, placing them in charge of all healthcare decisions affecting 
them.  
Weaknesses. The program’s  identified weakness was its ability to be spread throughout 
other VA facilities, due to primarily the PACT providers’ resistance to change from the 
traditional method of delivering opioid safety training during routine in-office appointments. 
Additional weaknesses included not all Veterans reliant on chronic opioids in the SMAs due to 
work or family constraints and those uncomfortable in group settings.   
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Opportunities. Opportunities were identified, such as inviting PACTs who had not yet 
integrated opioid reduction strategies to observe SMA sessions while progressing to understand 
the potentially improved outcomes from running group appointments. Another opportunity of 
this project was in the potential cost savings, as multiple patients could be seen during one SMA. 
The opportunity exists for future grant funding to assist with the spread of the opioid safety 
program enterprise-wide. An additional opportunity is for the success of this QI project to be 
spread to other VA facilities nationwide.   
 Threats. Identified threats included PACTs deciding to deviate from the specified 
training curriculum to educate their patients on opioid safety. Additionally, there was reluctance 
from PACT staff  to explore what really mattered in their lives with their patients. Other threats 
included that Veteran participation in SMAs was voluntary, which may have negatively affected 
attendance. Finally, Veterans may be resistant, fearful, physiologically dependent, or not ready to 
make whole health changes. Like so many initiatives and programs, a major barrier for spreading 
this program was the Coronavirus pandemic that ravished our nation. As of March 2020, the all-
hands-on-deck philosophy was applied to all healthcare personnel in combating the historical 
virus. Due to infection control practices and social distancing requirements, all face-to-face 
appointments and group meetings were cancelled until further notice. Mitigation plans have 
included working with Veterans to find alternative approaches that would be acceptable and 
effective for managing their pain. As a transformational leader, during this pause, the author has 
remained passionate and connected with every PACT team and all stakeholders to maintain this 
important project’s work. The use of systems thinking helped to overcome uncontrollable 
barriers by finding new methods to understand and revise the nature of things, to include how to 
intervene to improve population health (Peters, 2014).  
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Project Budget  
Although hard to quantify, the major return on investment from this DNP project was 
assisting Veterans in decreasing their opioid reliance. The budget (see Appendix I) for this 
project included the following staff salaries needed to conduct a 90-minute SMA: $154 for the 
PC physician, $45 for the RN, $31 for the LPN, $27 for the MSA, and $85 for the pharmacist, 
totaling $342 in personnel costs. The full opioid safety SMA program was comprised of nine 
sessions, with personnel costs totaling $3,078.  
The total budget to complete this project for the first year, comprised of 12 SMAs, was 
$9,653, with a projected 2% cost of living increase for the subsequent two years. A one-time, 
upfront training requirement to attend the mini-residency to prepare the staff to conduct an SMA 
was required at the cost of $5,496, which included $53 for printing educational materials and 
plastic binders training materials collected throughout the SMAs.  
Although no additional revenue was directly placed back into the budget, in the end, 
these healthy behavior changes could eventually impact Veterans’ lives and result in less drain 
on the VA healthcare system. Data specific to associated healthcare expenditures related to 
opioid reductions were not found in the review of literature. Veterans potential benefits in life-
long, healthy behavior changes, including decreasing their opioid reliance, may far outweigh the 
minimal costs associated with conducting a 9-week SMA on opioid safety.  
 Responsibility/Communication Plan 
The communication plan included keeping all stakeholders aware of the project’s 
progression from initiation through completion (see Appendix J). To achieve this plan, weekly 
meetings with the University of San Francisco (USF) advisor, Dr. Mary Lynne Knighten, via 
phone, email, zoom, or text messages, were conducted. Monthly meetings occurred with the 
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ELT, director of PC clinics, and fellow team members. Additional weekly meetings were 
conducted with the field advisor at the project site. Monthly meetings were conducted with the 
lead pharmacist and University of Alabama faculty member, who served as an on-site mentor to 
the author through the completion of the project.  
Cost-Benefit Analysis  
The author’s business plan for implementing an opioid safety SMA program was a cost-
benefit venture, in that opioid safety education was provided for up to 20 Veterans in a group 
setting over 90 minutes at a cost to the organization of $342 per SMA, versus the present option, 
where 20 Veterans received opioid safety education via routine office visits at $250 per visit, for 
a cost of $5,000. A cumulative annual cost avoidance of $62,424 (for 20 Veterans) will be 
realized within three years of program implementation (see Appendix K). The financial analysis 
reflected variations in the way we provide opioid safety education to our Veterans and provided 
an opportunity to improve future care delivery throughout the VA enterprise.  
A cost-benefit analysis for achieving this goal yielded a strong return on investment, with 
a projected cumulative 3-year cost-benefit of $51,970.06. Along with the potential 3-year cost-
benefit, the intangible benefits of implementing an opioid safety SMA program included 
providing education in a humane, patient-centered, compassionate manner. The DNP project 
aligned with the Birmingham VA Medical Center’s mission to honor Veterans by providing 
exceptional healthcare that improves their health and well-being. Additionally, the author’s 
financial analysis was directly aligned with DNP Essential II: Clinical Scholarship and 
Analytical Methods for Evidenced-Based Practice (American Association of Colleges of 
Nursing, 2006).  
WHOLE HEALTH OPIOID SAFETY PROJECT  36 
 
In addition to the number of lives lost each year to opioid overdoses, the opioid crisis has 
had a significant financial impact on our nation. Current estimates from the CDC reflect an 
estimated $78.5 billion a year economic burden from the opioid crisis, which includes healthcare 
costs, productivity losses, treatment for addiction, and criminal justice involvement (NIDA, 
2019). Results support the SMA whole health conceptual framework model utilizing an 
interdisciplinary staff as a cost-effective approach to reduce opioid reliance and improve opioid 
safety in a Veteran population.   
Study of the Interventions 
            Continuous Quality Improvement (CQI).  The author’s chosen CQI approach used to 
assess the impact of the interventions in this project used the four stage, problem solving model 
of plan, do, study, act (PDSA; see Appendix L). The use of a PDSA model was chosen as it 
provided the author a scientific method to determine if the interventions led to achieving the 
projects aim (Institute for Healthcare Improvement, 2016).  
This change of practice DNP project required a review of existing clinical practices for 
delivering opioid safety education at the project site. Evaluation of clinical data from 
retrospective record reviews was conducted to establish whether the outcomes were due to the 
interventions. Record reviews, also known a chart reviews, are a frequently used process to 
collect retrospective data to answer clinical questions (Sarkar & Seshadri, 2014). To ensure the 
accuracy and quality of the extracted data, the author personally completed all record reviews. 
The data collection instrument used was a de novo form without established validity or reliability 
and has been identified as a valuable lesson learned from this study. 
Outcome Measures 
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Comparisons were made between the opioid safety outcome measures of those who 
received training via Cohort I, comprised of a PACT team that met monthly over nine months 
and included health coaching, to Cohort II, comprised of PACT staff that met weekly over nine 
weeks and excluded health coaching, to Cohort III (control), who received training via routine, 
status quo, in-office education only. The following outcome measures were selected to 
accurately represent the phenomenon under study, based on their impact on the safety of the 
Veteran population:  
1. The MEDD 12 months post-program completion compared to the MEDD pre-SMA.  
2. A reduction in the pain score 12 months post-program completion compared to the 
pre-SMA score. 
3. An increase in CAM usage 12 months post-program completion compared to pre-
SMA usage. 
4. A comparison of outcomes and efficacy after 12-month completion of SMA related to 
eliminating health coaching from the standard of care used by Cohort II pre-SMA.  
To ensure the data collection’s completeness and accuracy, the instrument used for this QI 
project was a retrospective record review completed by the author. The author had planned to 
collect data from the PROMIS 29 form (see Appendix M) and a de novo Report Cards (see 
Appendix N) of SMA participants to assess their well-being and satisfaction; however, a random 
review revealed a systems issue in the form collection process. Therefore, all data were collected 
from retrospective reviews of computerized records of Veterans who participated in SMAs on 
opioid safety. All measures were recorded pre- and post-SMA and in-office visits. Descriptive 
statistics described trends in the data. The author obtained input from patients, staff, and 
leadership at the project site regarding their perspectives on this DNP project’s chosen measures. 
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Before this change of practice DNP project, the author was unable to locate any evidence in the 
literature, or at the local level, of satisfaction or cost measures being evaluated related to 
decreasing opioid reliance using a whole health approach.   
Analysis 
The intended outcomes measures for this DNP project were as follows: a reduction in 
MEDD and pain scores and an increase in the use of CAMs for the management of pain. Results 
of pre- and post-SMA statistical and clinical findings are displayed in Table 1 in Section IV. 
 The quantitative data regarding MEDD and pain scores were obtained from retrospective 
record reviews. The qualitative data regarding the use of CAMs were obtained from retrospective 
record reviews. The author performed the retrospective record reviews. The data were collected 
using a de novo collection tool (see Appendix O). The author was assisted by an expert in 
statistics at the project site in extracting outcome data into an Excel spreadsheet, displayed as 
column charts. The data were stratified into three levels of variables, to include comparison 
groups of Veterans who have participated in the original team’s opioid safety SMA over nine 
months with health coaching, to those who participated in another PACT’s SMA over nine weeks 
without health coaching, to those Veterans who received in-office opioid safety education only. 
Time was recognized as a variable; in that Cohort I held their SMAs over nine months versus 
Cohort II, who held their SMAs over nine weeks. To determine the statistical significance, a p 
value of 0.05 was established. To determine clinical significance, a percentage change of 
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Ethical Considerations 
On August 20, 2019, the USF DNP department determined that this project met the 
guidelines for an evidence-based change of practice project, as outlined in the DNP project 
checklist (statement of determination) and was approved as non-research (see Appendix P). 
Additionally, a statement of non-research determination was obtained from the VA (see 
Appendix Q). Prior to project implementation, the author completed a Human Subject Research 
course provided by the Collaborative Institutional Training Initiative. The VA facility leadership 
fully supported this project (see Appendix R). Issues with patient privacy concerns and the 
protection of participants’ physical and psychological well-being were safeguarded in this 
project, as data were obtained via a retrospective record review using the computerized patient 
record system. This project complied with the Health Insurance Portability and Accountability 
Act, as names and identifiers were not collected, and all data were presented in aggregate form. 
No conflicts of interest were identified.  
Jesuit Values 
This QI project was directly congruent with the USF’s Jesuit values for treating Veterans 
with respect and dignity while partnering with them in shared decision-making. In addition, it 
aligned with the Jesuit value of Cura Personalis, which means caring for the whole person with 
respect to their intellectual, spiritual, and physical health and autonomy (USF, 2019). Jesuit 
values and code of ethics values were clearly demonstrated in this project.  
ANA Ethical Standards  
Notably, Pender’s HPM and the VA’s whole health model, which served as the 
foundation for this project, aligned with the Jesuit value of caring for the whole person and the 
value of forming and educationg agents of change. Furthermore, in alignment with the American 
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Nurses Association’s (2015) Code of Ethics and Interpretive Statements, this project has added 
to the nursing profession by advancing scholarly inquiry in the area of health, safety, and well-
being. Compassion and respect were shown for the participants involved in this study, both 
individually and collectively, throughout this project. 
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Results 
The initial steps of the interventions included randomly assigning study participants into 
three cohorts. Modifications to the initial interventions were not needed and remained consistent 
throughout this change of practice DNP project. Data were collected before and after patient 
participation for each study group. A two-tailed, paired t-test was performed, with a p-value of ≤ 
0.05 selected to indicate significance. As introduced earlier, clinical significance was calculated 
by percentage change pre- and post-SMA results. 
Quantitative Findings 
The project’s sample size (n = 90) comprised Veterans on chronic opioids receiving care 
at the project site. As displayed in Table 1, data analysis revealed the only cohort with a 
statistically significant reduction in MEDD was Cohort I (p < 0.0063). Cohort  II was the only 
one that made a statistically significant improvement in pain scores (p < 0.0202) and CAMs (p = 
0.0117). However, in looking at the magnitude of change between the variables pre- and post-
SMA, patients in all three cohorts made clinically significant improvements in reducing MEDD 
and pain scores and increased use of CAMs. These findings demonstrate proof of concept for the 
promise of SMAs in managing chronic pain in this population. Clinical improvements for each 
variable and cohort are reflected in percentages in Table 1. 
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Table 1 




Cohort I (n = 30) 
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*P-value of ≤ 0.05 selected to indicate significance. 
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The first major clinical outcome of this change of practice DNP project was that each of the three 
cohorts made clinical improvements reducing MEDDs and pain scores and in increasing the use 
of CAMs.  
Clinically Significant Findings 
As compared to the above statistical findings, clinically significant findings of this study 
reflect the magnitude of change the intervention made on clinical practice and the quality of life 
for Veterans (Ranganathan, Pramesh, & Buyse, 2015). Of the 90 patients, 36 patients made 
reductions in their MEDD, 31 patients reported lower pain scores, and 19 patients added a CAM 
into their plan of care.  
            Clinical improvement in MEDD.  Of the 30 patients in Cohort I, 13 patients reduced 
their MEDD, for a combined reduction of 21%, compared to Cohort II, where 10 patients 
reduced their MEDD, for a combined reduction of 2.3%, compared to Cohort III, where 13 
patients reduced their MEDD, for combined reduction of 0.5%. The total MEDD percentage 
change post -SMA was 2,567.14 milliequivalents, compared to pre-SMA of 3,169.64 
milliequivalents, for a combined 21% reduction.  Cohort II MEDD post-SMA was 965 
milliequivalents, compared to pre-SMA of 987.5 milliequivalents, for a combined reduction of 
2.3%. Cohort III (control) MEDD post-SMA was 1457 milliequivalents, compared to pre-SMA 
of 141464, for a combined reduction of 0.5%. 
            Clinical improvement in pain scores.  Of the 30 patients in Cohort I, nine patients 
reduced their pain scores, for a combined reduction of 29%, compared to Cohort II, where 14 
patients reduced their pain scores, for a combined reduction of 46%, compared to Cohort III, 
where eight patients reduced their pain scores, for a combined reduction of 27%. 
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            Clinical Improvement in Use of CAMs.  Of the 30 patients in Cohort I, seven patients 
increased their use of CAMs, for a combined increase of 23%, compared to Cohort II, where six 
patients increased use of CAMs, for a combined increase of 20%, compared to Cohort III, where 
six patients increased use of CAMs, for a combined increase of 20%. 
The second outcome from this change of practice DNP project was developing a Veteran 
toolkit for use during future SMAs. The toolkit was developed based on requests from PACTs 
for a consolidated packet of training materials to conduct opioid safety SMAs.  The toolkit will 
benefit VA providers and clinicians who assist countless Veterans participating in the whole 
health opioid safety SMAs, both locally and nationally. The guide directly aligns with the 
Veteran Toolkit and will provide a consistent, standardized curriculum to deliver opioid safety 
education.  
Missing data in this change of practice DNP project include participant demographic data 
of age, gender, and race, which have been identified as weaknesses of this study.    




The overarching aim of this DNP project was: By September 2020, 30 Veterans at the 
VA project site who participated in a 9-month whole health opioid safety SMA led by PACT 
staff to include a health coaching component would have a 10% or greater decrease in the 
MEDD and decreased pain scores and a 10% increase in the use of CAMs for pain management, 
compared to 30 patients who participated in a 9-week whole health opioid safety SMA led by 
PACT staff without health coaching, compared to 30 Veterans who received in-office opioid 
safety education. The outcome data from record reviews pre- and post-SMA provided evidence 
that the DNP project aim was successfully achieved with two of the three proposed outcomes 
within one year of implementation of the program. Based on the outcome data from Cohort I, the 
author believes the use of health coaching over nine months conducted in a group setting made 
the greatest contribution to project’s success.  
The chosen theoretical frameworks selected for use in this change of practice DNP 
project provided a firm foundation for building the whole health curriculum, focusing on the 
concept of self-efficacy for Veterans decreasing their opioid reliance. 
This QI project’s findings reflect that clinical improvements can be achieved when 
patients receive opioid safety education, are offered alternatives to manage their pain, receive 
health coaching, and set their own SMART goals. A second major outcome was the development 
of a Veteran toolkit for use during future SMAs. Although not originally intended, a third major 
outcome creating an Implementation Guide for PACT teams to use for launching opioid safety 
SMAs in other clinics and facilities. A copy of the Implementation Guide’s index is included in 
Appendix S. 
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A valuable lesson learned from this project includes the importance of developing a 
comprehensive, validated data collection tool prior to conducting record reviews. Such a tool 
would have saved the author valuable time and would have added to the credibility of this 
project. 
Several assumptions can be made from the results of this DNP project. Cohort I achieved 
a 21% decrease in MEDD. In part, results may reflect unique contributions of coaching and 
interventions of prolonged duration of nine months, compared to nine weeks in Cohort II and III. 
Self-efficacy, or the belief in one’s capacity to produce change, plays a critical role in behavior 
change and requires behavioral feedback over time (Bandura, 2013). Therefore, Cohort I’s 
reported a significant reduction in MEDD outcomes may have been due to its members having 
the opportunity to collect behavioral feedback and foster self-efficacy. Provider effects, or 
systematic effects of provider, on outcomes beyond treatment modalities, may also have 
contributed to observed outcomes (Lutz & Barklam, 2015).  
An additional assumption is that Cohort I’s primary goal in implementing SMAs was to 
reduce opioid usage, In contrast, Cohort II and III may have emphasized on the use of CAMs to 
manage their pain. In analyzing Cohort I’s outcomes, an incidental finding was detected in 
participants achieving a statistically significant decrease in their MEDD, without achieving a 
statistically significant increase in their pain scores, indicating even though their opioid dose was 
decreased, the participants’ pain did not statistically increase. This may be attributable to a 
lagged response and may result in future reported pain scores. Additionally, the possibility of a 
placebo effect occurring of Veterans believing they were going to improve; therefore, they did 
(The Placebo Effect, May 2019). 
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Assumptions can be made that patients may have difficulty distinguishing changes in 
their pain perception due to the chronicity of pain. A condition known as opioid-induced 
hyperalgesia has been found to create a paradoxical response in certain patients on chronic 
opioids; whereby, the treatment of pain causes the patient to become more sensitive to painful 
stimuli (Lee, Silverman, Hansen, Patel, & Manchikanti, 2011). Additionally, opioid tolerance, 
defined by Colvin, Bull, and Hales (2019) as the increased need for analgesia, is a condition that 
affects certain patients on chronic opioids, which may explain the lower change in pain scores in 
Cohort I and III. 
Cohort II’s and Cohort III’s reduction in MEDD may be due to increased monitoring of 
provider’s adherence to CDC and VA opioid prescribing guidelines, to include tapering methods 
to reduce patient’s chronic opioid usage (Dowell, Haegerich, & Chou, 2016; U.S. Department of 
Veterans Affairs, 2017). 
Cohort I achieved a 29% reduction in pain scores, compared to Cohort II (46%) and 
Cohort III (27%). Cohort II’s and Cohort III’s reductions in pain scores may be due to higher 
MEDD trends and increased emphasis on using CAMs to manage their pain. The reductions in 
reported pain scores in all three cohorts may be attributable to the team’s focus on increasing the 
use of CAMs to control pain. Additional psychological factors of the participants, such as 
depression, anxiety, or level of coping skills, have been shown to influence variability in 
reporting pain levels (Schneider et al., 2012). 
Clinical improvements were observed in pain score and complimentary medicine of 
Cohort II and Cohort III participants; however, these findings must be interpreted with caution 
due to the higher MEDD trend of both groups. Cohort I achieved a 23% improvement in use of 
CAMs, compared to Cohort II and Cohort III, who achieved a 20% increase in CAMs. Cohort I’s 
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higher percentage may be due emphasis placed on using CAMs over medication for pain relief. 
To determine if access was a variable in patients increasing their use of CAMs, the author met 
with the administrative officer in charge of scheduling CAM appointments and determined equal 
accessibility to appointments at each cohort location. Additionally, increased usage of CAMs in 
Cohort II and Cohort III may have increased promotion by the PACT team. Cohort III’s (control) 
method of providing opioid safety training using the status quo mode of delivering in-office 
sessions without a whole health set curriculum or health coaching may have contributed to their 
lower percent of MEDD reductions. An assumption can be made that Cohort III’s in-office 
education was geared toward the provider’s goal of decreasing MEDD, with little input from 
their patients on how to proceed with their pain management and whole health goals. An 
additional assumption can be made that the 20% increase in the use of CAMs in Cohort III was 
attributable to the provider’s efforts and external pressures to address their patients’ pain without 
increasing their MEDD. 
Upon completion of the program, a new possibility for change occurred. Several 
participants expressed their desire to attend ongoing sessions to maintain their momentum and 
achieve progress in meeting their SMART goals. In response, and as part of the team’s 
sustainability plan, monthly maintenance SMAs have been held for participants to continue their 
whole health journey. To familiarize SMA participants and staff with using virtual training 
platforms during the pandemic, education was provided by the implementation team and 
telehealth staff. Reference sheets with instructions were sent to each participant prior to the SMA 
start date. To date, ten virtual opioid safety SMAs have been successfully conducted, with an 
average of six Veterans per session. 
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Dissemination Plan 
              As a result of the team earning Gold Fellow Status from the VA Diffusion of Excellence 
Shark Tank competition, future dissemination plans of this best practice are to spread the 
approach and to sustain the process improvement, to include offering ongoing opioid safety 
mini-residency training to VA facilities, both locally and nationally. The team’s latest spread 
includes training three PACTs using VA Video Connects virtual platform for a VA facility in the 
Northeast United States.  
Unanticipated Outcomes.   
           Although not originally intended, based on requests from interested PACT teams, a major 
outcome of the project was creating an Implementation Guide (see Appendix S) for PACT teams 
to use for launching opioid safety SMAs in other clinics and facilities. The guide will provide a 
consistent, standardized curriculum that will support the patient toolkit.  
           An outcome from this DNP change of practice project provided the opportunity and 
capacity to sustain support for Veteran’s behavior change was based on the request from 
participants to attend “alumni” SMAs after they completed of the nine-session program. As of 
October 2020, three groups of graduates have continued their whole health journey by attending 
monthly SMAs. 
          An additional opportunity arose during this project for the author to contribute to the 
publication of the American Hospitals Association (AHA) Opioid Stewardship Guide. Once fully 
launched, the guide, will be distributed to all U.S. hospitals to share best practices regarding 
opioid safety and care delivery nationally. The author’s contribution to the guide included 
sharing the use of SMAs to help reduce opioid reliance in the Veteran population using a whole 
health approach.  
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As a result of earning Gold Level Status from the VA Diffusion of Excellence Shark Tank 
competition, disseminating this best practice has been spread to three PACTs at the Boston VA.  
Future plans include combining data from the Boston VA with that from the author’s project site 
to compare and contrast data from a national perspective, to include possible publication.  
As the COVID-19 pandemic moves forward, so does the opioid epidemic, as recent data 
indicate an 11.4% increase in opioid deaths occurring in January 2020, compared to the same 
period in 2019 (Advisory Board, 2020). The current Covid-19 related public health measures, 
such as shelter-in-place orders, have caused patients battling with sobriety and addiction to lose 
their support networks, resulting in feelings of isolation (Silva & Kelly, 2020). Although 
necessary, such public health measures to turn the pandemic’s tide have been linked to poor 
mental health outcomes due to repercussions from fear, job loss, and need for social distancing. 
(Panchal et al., 2020).  
To combat feelings of isolation and anxiety over not being able to connect to their 
healthcare team, the whole health opioid safety SMA team at the project site has started a series 
of weekly, virtual sessions via the VA’s Video Connect platform. To date, the staff have held 12 
SMAs using this virtual platform and have found Veterans receptive and excited about 
connecting and seeing their healthcare team on their computer screen. Sessions have included 
opioid safety measures, healthy eating, weight gain, body movement, and health coaching, where 
discussions have centered on the Veterans current goals, barriers to achieving goals, and potential 
options for their healthcare. Feedback to this point has been positive, with the same number of 
Veterans returning each week to the sessions. Several Veterans mentioned that they had not left 
their house for months and find these weekly sessions something they look forward to. A recent 
SMA discussion focused on sleep hygiene presented by a staff psychologist. Conducting virtual 
WHOLE HEALTH OPIOID SAFETY PROJECT  51 
 
whole health SMAs to reduce opioid reliance is expanding access to care for Veterans who would 
not routinely travel to the VA during this pandemic to receive supportive care. By continuing 
virtual SMAs during the pandemic, the team hopes to build trust with their patients and provide a 
sense of connectivity during these uncertain times. The team strongly believes this connectivity 
has empowered the Veterans to become in charge of their healthcare decisions during these 
uncertain times.  
As a DNP-prepared leader, the author’s future plans to influence the VA culture and 
external healthcare systems to adopt this approach include promoting the ease of program 
implementation and sharing the team’s expertise and resources via mini-residency training. 
Additionally, the author will continue to present program successes on VA community of 
practice calls, reaching approximately 500 PC team members nationwide.  
This change of practice DNP project has direct implications for advanced nursing 
practice, as it provides an opportunity for nurses to promote whole health opioid safety SMA 
programs, which have the potential to change lives, decrease the risk of opioid addiction, and 
influence future practice guidelines for addressing our nation’s opioid crisis.  
     Interpretation 
It can be inferred from the results of this DNP project that a one-size-fits-all approach 
does not exist for resolving the opioid crisis. However, the evidence from this project supports 
using whole health opioid safety SMAs can have a positive clinical effect on decreasing MEDDs 
and pain scores and increasing the usage of CAMs for pain management, despite variations in the 
approach. Positive results from this project were similar to outcomes from teams who used 
SMAs to impact other health conditions, such as diabetes and hypertension (Cain et al., 2017; 
Drake et al., 2018; Edelman et al., 2012; Omogbai & Milner, 2018). Results of this study 
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indicate that the clinical improvements made by patients in this study and the benefits of 
conducting opioid safety SMAs far outweigh the costs.  
The results of this change of practice DNP project have direct implications for replication 
at other VA healthcare facilities, requiring involvement from both senior nursing executives and 
staff development professionals. Future implications for PACTs and staff development personnel 
include the ability to access the Veteran Toolkit and Implementation Guide to conduct future 
SMAs in their facilities.  
Valuable outcomes for this project included Veterans who participated in SMAs with 
health coaching demonstrated a statistically significant decrease in their MEDD usage, compared 
to Veterans who attended SMAs without health coaching and those who received opioid safety 
education delivered in the traditional status quo mode of in-office education. However, at this 
time, the author does not have follow-up data and, so cannot speak to the intervention’s 
sustainability. Results from Cohort III indicate maintaining the status quo in delivering opioid 
safety education did not make a statistically significant difference in impacting MEDDs, pain 
scores, or use of CAMs to manage pain; however, clinical improvements in each measure were 
achieved. Findings support the HPM and whole health conceptual frameworks used in this DNP 
project. The proposed financial estimates for conducting this project were forecasted accurately 
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Limitations 
The study’s limitations should be acknowledged, including the retrospective data 
collection, differences in patient and team composition demographics, and institutional variance 
in implementation (9-month versus 9-week) SMAs. Additional limitations include that SMAs 
were conducted in a single VA facility and involved only Veterans in group settings, affecting 
the study outcomes. The small sample size of reviewed records (n = 90) may not have been 
adequate for detecting a statistically significant difference between the three groups of Veterans. 
The small number of studies and the study design may have limited the number of conclusions 
that could be drawn concerning the evidence-based practice question and aim. Also, Veterans 
may have been unable to participate in SMAs due to travel restrictions, travel costs, discomfort 
in groups, or mobility issues. Attendance, sex, race, and age demographics for the  study 
participants were not collected and are identified weaknesses of this project. Reported pain 
scores were subjective and easily influenced by numerous objectives, such as time of day and 
state of mind. An identified weakness was the inability to collect qualitative findings for well-
being and satisfaction via valid and reliable instruments (PROMIS 29 and de novo Report Cards) 
due to the lack of a standardized approach for collecting the forms. This system issue has been 
corrected for teams moving forward. 
Identified barriers to the successful implementation of this program included lack of 
engagement by Veterans and staff in conducting and attending the weekly sessions. The program 
required time commitment and willingness to arrange schedules to participate. Additional 
barriers included difficulty in securing meeting space and obtaining protected clinic time to 
conduct the SMAs. Finally, an identified barrier for this change of practice DNP project was the 
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potential for leadership support to dwindle due to competing priorities, such as staff realignment 
during the Covid-19 pandemic. 
Strategies to mitigate the noted limitations included the author presenting at various 
PACT staff meetings and morning huddles, sharing outcome data, and offering educational and 
logistical support for implementing SMAs. Additional future efforts could include leadership 
support in offering lunch-and-learn sessions to provide information on the severity of the opioid 
crisis impacting the Veteran population. Signage to provide awareness of the opioid crisis was 
placed around the project site, including elevator wraps (see Appendix T) and flyers promoting 
the importance of whole health modalities (see Appendix U). The COVID-19 pandemic has 
stretched the implementation team to find innovative modalities to conduct SMAs via telehealth 
platforms in lieu of face-to-face group sessions. The project site did not have locally distinctive 
characteristics that impacted the implementation of this DNP project. Although some selection is 
bias inherent, the findings of this study suggest benefit from conducting SMAs that incorporate 
health coaching over a longer period. Future studies are warranted to support these findings. 
Meaningful and logical next steps that could extend and compliment this study include forming 
larger cohorts, conducting and collecting SMA data from other VA facilities, and collecting 
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Conclusions 
Results of this evidenced-based change of practice DNP project indicate the use of opioid 
safety SMAs using a whole health approach is a simplistic, cost-effective, and innovative 
approach to addressing a complex problem, the opioid crisis. The most significant result of this 
project was establishing an evidence-based, cost-effective approach that can be implemented in 
VA and non-VA facilities, which has shown to lead to sustained clinical improvements in 
MEDD, pain scores, and use of CAMs for managing pain. Each of the three cohorts in this 
project demonstrated clinical improvements, regardless of the approach used. This innovative 
program’s primary goal was to fill the existing gap between the status quo of delivering opioid 
safety education by implementing SMAs using a whole health approach for managing pain and 
saving the priceless lives of thousands of American Veterans. Achieving this goal demonstrated 
a decrease in opioid usage and pain scores and an increase in the use of CAMs for managing pain 
in a Veteran population.  
Spread of this practice has the potential to improve the lives of Veterans with chronic 
pain and chronic opioid reliance. Key findings from this project support using the SMA whole 
health conceptual framework utilizing an interdisciplinary staff as a mode to reduce opioid 
reliance, decrease opioid usage, and improve opioid safety in a Veteran population. The HPM, 
paired with the whole health model, provided the framework for this project for Veterans to 
identify interventions based on their perceived strengths, self-efficacy, and potential benefits 
from making lifestyle changes through creating SMART goals. Further investigation is needed to 
investigate this topic of interest. 
The intangible benefits of implementing a whole health opioid safety SMA program 
include providing education in a humane, patient-centered, compassionate manner. The author 
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believes that it is no coincidence that this change of practice DNP project is being completed in 
September, during the observance of National Recovery Month. The purpose of this designation 
is to educate Americans that with help, those with a substance abuse disorder can live a 
rewarding and healthy life and reinforces that behavioral health is essential to overall wellness 
(National Association for Alcoholism and Drug Abuse Counselors, n.d.). The opportunity to 
answer our nation’s call to defeat the opioid crisis will require a steady hand, strong leadership 
support, and a multi-pronged approach using interdisciplinary healthcare staff. The knowledge 
obtained through the USF’s DNP-EL program will position the author perfectly to begin to 
change the world from here. 




This DNP project did not receive funding from any organization influencing the design, 
implementation, interpretation, or reporting of this work. 
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Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
 Betthauser, L. M., Brenner, L. A., Forster, J. E., Hostetter, T. A., Scheider, A. L., & Hernandez, T. D. (2014). A factor analysis and exploration of attitudes and beliefs toward   
      complementary and conventional medicine in veterans. Medical Care, 52(12), S50- S56. doi:10.1097/MLR.0000000000000219  
Purpose: 







































































analysis with a 























Level III, A/B 
(High/Good Quality) 
Worth to Practice: Veterans 
believed that complementary 
modalities involving the mind and 
body should be incorporated into 
their care. Finding may assist 
providers in understanding Veterans 
willingness to use CAMs. 
Feasibility: CAMs cost-effective 
for pain management 
Strengths: Veterans endorsed a 
wide range of CAM alternatives to 
manage pain. 
Weaknesses: Small sample size, no 
conceptual framework noted. 
Conclusions: Veterans who 
participated in this study were 
receptive to the use of 
complementary modalities. 
Recommendations: Will 
incorporate findings into project to 
support importance of CAM usage 
as alternative for opioid usage to 
manage pain. 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
C    Cain, E. K., Gordon, A. N., Mooney, K. D., Aikens, G. B., Robinson, M. H., & Howard, M. E. (2017). Impact of shared medical appointment on hypertension clinical outcomes   
            and medication adherence in a Veteran’s affairs health care system. Journal of Pharmacy Technology, 33(5), 177-182. doi:10.1177/8755122517714578  
Purpose: This 
purpose of this 
QI study was 



















were on a 
minimum of two 
hypertension 
medications, had 
a systolic blood 
pressure (SBP) 
of >140 mm Hg 
or diastolic blood 
pressure (DBP) 







received care at 











Positive effect on 














SBP reduction of 

























using a paired, 





















Level III, A/B 
(High/Good Quality) 
Worth to Practice: SMAs growing 
in popularity in PC settings 
Feasibility: SMAs cost-effective 
approach for impacting clinical 
results (HPN) 
Strengths: Utilized inter-
disciplinary team to conduct SMAs, 
Strong QI study, easily reproducible 
in like settings  
Weaknesses: Study points out that 
a Gold Standard for conducting 
SMAs is lacking 
Conclusions: Veteran diagnoses, 
suggests strong linkage between 
strength of education in group 
settings over individual office 
appointment education.  
Recommendations: Study findings 
will be incorporated into DNP 
project to support the use of SMAs 















Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Chen Y., Shiels, M. S., Thomas, D., Freedman, N. D., & Berrington, A. (2018). Premature mortality from drug overdoses: A  comparative analysis of 13 organization for economic 













































to extract the 
annual number 













Premature death rates 



















four authors of 
the study 
between 2001 




















linked to the 
three waves 
of the U.S 
opioid crisis 
Rating: 
Level V, A 
(High Quality) 
Worth to Practice: Study findings 
support the need for an immediate 
solution to address the opioid crisis 
Feasibility: Study supports use in 
project depicting severity of opioid 
crisis 
Strengths: Used large, international 
sample from 13 countries 
Weaknesses: Study failed to 
compare impact of specific drugs 
effecting death rates by country 
Conclusions: The alarming 
statistics point to the urgent need to 
find a solution for resolving the 
opioid crisis 
Recommendations: Statistics 
provided in this study will be used 
to support project and provide an 
impetus for a solution to positively 
impact the alarming death rates due 















Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
 Christie, C., Baker, C., Cooper, R., Kennedy, P. J., Madras, B., & Bondi, P. (2017). The president’s commission on combating drug addiction and the opioid crisis. Retrieved from:   







































Christie led a 
Commission to 
assist the 































verbally to the 



















Level IV, A/B 
(High/Good) Quality 
Worth to Practice: The numerous 
recommendations to include 
increased media coverage via an 
opioid awareness campaign, data 
sharing, mental health services, 
state-based drug monitoring 
programs may inform clinicians and 
national leaders of the severity of 
the opioid crisis 
Feasibility: Actions and 
recommendations from the expert 
panel support need for immediate 
action in resolving opioid crisis and 
supports project 
Strengths: Panel comprised of 
subject matter experts 
Weaknesses: None noted 
Conclusions: A multi-pronged 
approach is needed to address the 
opioid crisis facing the U.S. 
Recommendations: Data and 
recommendations from this expert 














Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Drake, C., Meade, C., Hull, S. K., Price, A., Snyderman, R. (2018). Integration of personalized health planning and shared medical appointments for patients with type 2 diabetes 





























































































Level II, A/B 
(High/Good) Quality 
Worth to Practice: Use of the 
PHP’s in SMAs can assist clinical 
teams in impacting DM related 
outcomes 
Feasibility: Cost-effective approach 
to achieve clinical outcomes 
supports whole health approach 
conceptual framework of project 
Strengths: Results of incorporating 
PHP into SMA would be a simple 
process to replicate 
Weaknesses: Small sample size 
Recommendations: Findings will 
be used in project to support use of 






















Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Edelman,  D., McDuffie, J. R., Oddone, E., Gierisch, J. M., Nagi, A., & Williams, J. W., Jr. (2012). Shared medical appointments for chronic medical conditions: A systematic   





















































































that have a 
high-risk of 
complication










Level II A/B 
(High/Good) 
Quality 
Worth to Practice: SMAs can 
positively affect clinical outcomes 
such as DM 
Feasibility: SMAs are effective in 
positively impacting clinical and 
economic outcomes, satisfaction of 
participants and staff 
Strengths: Large sample size of 
RCTs 
Weaknesses: None noted 
Conclusions: Reviews showed that 
using SMAs in small, closed 
groups, providing breakouts for 
medication management improved 
outcomes for Type 2 diabetes to 
include reductions in HBG A1C, 
systolic blood pressure 
Recommendations: 
Study findings will be incorporated 
into project to support the use of 














Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Edmond, S. N., Becker, W. C., Driscoll, M. A., Decker, S. E., Higgins, D. M., Mattocks, K. M., & Haskell, S. G. (2018). Use of  non-pharmacological pain treatment modalities    



























defined as lasting 
























































Rating: Level II A/B 
(High/Good Quality) 
Worth to Practice: NPMs can be 
alternative to opioid usage  
Feasibility: NPMs are a cost-
effective, safe alternative for 
managing clinical outcomes 
Strengths: Moderate sample size, 
including adequate sample of 
female Veterans 
Weaknesses: Limited by cross-
sectional design 
Conclusions: Further studies are 
needed to determine which NPM’s 
are most effective in of care for 
various groups of Veterans, specific 
to disease condition, and treatment 
preferences. 
Recommendations: Findings 
support project in use of NPMs as 



















Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Frank, J. W., Lovejoy, T. I., Becker, W. C., Morasco, B. J., Koenig, J., Hoffecker, L., … Krebs, E. E. (2017). Patient outcomes in   


















































abstracts of 67 


































to assess quality 


































Level II A/B 
(High/Good) Quality 
Worth to Practice: Value in 
providers discussing benefits of 
tapering LTOT and referring to 
interdisciplinary pain teams 
Feasibility: Cost-effective means to 
findi alternatives for managing pain 
Strengths: Study quality was good 
for three studies, fair for 13 studies  
Weaknesses: Heterogeneous 
interventions and outcome measures 
Conclusions: Evidence suggests 
that numerous interventions may 
reduce LTOY. Pain, function and 
the quality of life may improve 
when opioid doses are reduced 
Recommendations: Findings will 
be included in the project as 
evidence to support the use of 
various interventions as effective 
alternatives for LTOT 
 
 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Han, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones C. M. (2017). Prescriptive opioid use, misuse, and use disorders in U.S. adults. Annals of Internal Medicine, 









use by U.S. 
adults.  

































Survey on Drug 
Use and Health 
(NSDUH) 









National rates of 
opioid use, misuse, 

















(24) to account 
for the complex 
sample weights 

































Level III A/B 
(High/Good) 
Quality 
Worth to Practice: Prescribers can 
gain increased understanding of 
opioid use, misuse, and reasons for 
usage 
Feasibility: Study findings support 
urgency to find a solutionfor the 
opioid crisis and supports project 
Strengths: Large sample size 
Weaknesses: NSDUH excluded 
homeless person not living in a 
shelter, institutionalized residents, 
or active-duty military personnel 
Conclusions: 2015 survey data 
revealed more than one-third of U.S 
adults reported using opioids. 
Reduction from pain was the key 
motivator for using opioids.  The 
results indicate the need for 
expanding access to evidenced-
based pain management programs 
and to provide ongoing education 
on the use of these addictive and 
powerful medications 
Recommendations: Results will be 
integrated into the project as 
evidence to support of the severity 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 





































of the opioid crisis and the urgency 
to find a solution 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Nahin, R. L. (2017). Severe pain in veterans: The effect of age and sex, and comparisons with the general population. Journal of  Pain, 18(3), 247-254 











































from the 2010 -











Variable: Defined as 
a Veteran by either 
currently serving in 
the U.S. military or 












identified as having 
severe pain via the 
imbedded coding 




























used to assess 
the relationship 
between ordinal 


















of 56.4%, and 
severe pain at 
6.4%. 
 
Rating:   Level III A/B 
(High/Good) Quality 
Worth to Practice: Study points to 
the need for increased attention 
needed toward recognition and 
treatment of greater severe pain in 
the Veteran population 
Feasibility: Provides awareness of 
severity of pain in Veteran pop.  
Strengths: Large sample size, first 
study to compare severity of pain 
between U.S. military Veterans and 
non-Veterans 
Weaknesses: Cross-sectional data 
unable to prospectively 
Determine clinical outcomes, NHIS 
unable to retrieve information 
regarding pain treatment  
Conclusions: Prevalence of pain in 
Veterans compared to non-Veterans 
is alarmingly higher and must be 
addressed using evidenced-based 
modalities. The study recommends 
revised pain management strategies 
be offered to the Veteran population 
Recommendations: Study findings 
can be integrated into the project to 
support solution for managing 
severe pain in the Veteran 
population 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Omogbai, T., & Milner, K. A. (2018). Implementation and evaluation of shared medical appointments in patients with diabetes: A quality improvement study. Journal of Nursing 






























for this QI study. 






Sample: 30 male 
Veterans with 
DM who 








































three to six 































Level V, A 
(High Quality) 
Worth to Practice: SMAs can 
positively impact specific clinical 
outcomes 
Feasibility: Cost-effective means to 
assess impact of SMAs on clinical 
outcomes 
Strengths: Study guided by strong 
conceptual framework  
Weaknesses: Certain Veterans 
voiced reluctance to discussing 
health status during SMA; small 
sample size 
Conclusions: Results of this QI 
study indicates that SMAs can be an 
effective modality to influence 
clinical outcomes and satisfaction in 
Veteran patients with DM. 
Recommendations include 
spreading the use of SMAs VA-
wide for all Veterans with DM 
Recommendations: Results will be 
integrated into project as evidence 
to support use of SMAs to impact 













Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Rani, E. A., Johnston, J. M., Bormann, J. E., Hull, A., & Taylor, S. L. (2014). A systematic scoping review of complementary and alternative medicine mind and body practices to 









in the literature 
and to provide 
recommendatio













































National VA survey 
 
Dependent 
Variable: Use of 
mind-body practices 











reviews for inclusion 
on mind-body 
interventions used in 































Rating: Level III A/B 
(High/Good Quality) 
Worth to Practice: Beneficial in 
the primary care setting when 
planning approaches for future 
development of robust Veteran pain 
management plans of care 
Feasibility: Veterans open to mind- 
body interventions for managing 
pain 
Strengths: First systematic scoping 
review that reviewed all mind-body 
interventions specific to Veterans 
Weaknesses: Only articles 
published in English were included 
due to limited translation abilities; 
search strategy may have failed to 
identify all appropriate articles for 
inclusion in review 
Conclusions: Most prevalent mind-
body practices used by Veterans and 
military personnel were meditation 
and acupuncture. Further research is 
indicated for use of Yoga in the 
Veteran population 
Recommendations: Review of 
predominant mind-body 
interventions will be integrated into 
project to support use of mind-body 
modalities to manage Veterans pain 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
Romanelli, R. J., Dolginsky, M., Byakina, Y., Bronstein, D., & Wilson, S. (2017). A shared medical appointment on the benefits and risks of opioids is associated with improved 







































































































Level III A/B 
(High/Good) Quality 
Worth to Practice: SMAs can be 
an effective approach for improving 
patient confidence in managing pain 
Feasibility: Increased confidence to 
manage pain supports self-efficacy 
and whole health conceptual 
framework of prohject 
Strengths: Easy to replicate, cost-
effective, evidence-based 
Weaknesses: Study reviewed short 
term outcomes only, without a 
control group 
Conclusions: Patients demonstrated 
increased confidence in their ability 
and their healthcare team’s ability to 
manage pain increased through the 
use of SMAs. 
Recommendations: Results will be 
integrated into project to support 
importance of understanding 
Veterans confidence levels-self-
efficacy in managing pain 
 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 








































































from 1999 to 
2014, without 
a significant 










This rise in 
opioid-related 
overdose 
deaths can be 
attributed to 
three separate 
waves of  
lethal drugs: 
first wave of 
Rating: 
Level V A (Good Quality) 
Worth to Practice: Expert opinions 
regarding the urgent need for more 
funding to find an evidenced-based 
solution to the opioid crisis. A 
whole health opioid safety SMA can 
be part of the solution 
Feasibility: N/A 
Strengths: Provides history of 
opioid crisis in the U.S. and current 
severity 
Weaknesses: Expert opinions 
limited to two authors; systematic 
reviews of rigorous studies needed 
to make change 
Conclusions: Public health crisis of 
opioid addiction and death rates will 
require additional scientific 
leadership and funding to make 
needed changes, to include a 
national summit to create research 
agenda  
Recommendations: Much of the 
data needed to make change will 
require research from federal and 
agencies and foundations 
 
 









Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 












in the late 
1990s 





































Sample / Setting Major Variables 
Studied (and their 
Definitions) 
Measurement of 
Major Variables  
Data Analysis Study 
Findings 
Level of Evidence (Critical 
Appraisal Score) /  
 Worth to Practice / 
Strengths and Weaknesses / 
Feasibility / 
 Conclusion(s) / 
Recommendation(s) / 
 Wadsworth, K. H., Archibald, T. G., Payne, A. E., Cleary, A. K., Haney, B. L., & Hoverman, A. S. (2019). Shared medical appointments and patient-centered experience: A mixed 
      methods systematic review. BMC Family Practice, 20(1), 97.  doi:10.1186/s12875-019-0972-1 
Purpose: 





























































































































Level III A/B 
(High/Good) Quality 
Worth to Practice: Primary Care 
setting is most appropriate setting to 
conduct SMAs; improved resilience 
and enhanced coping skills are 
important outcomes of SMAs 
Feasibility: SMAs are cost-
effective delivery modality to 
improve clinical outcomes 
Strengths: Current review updates 
the evidence to support the use of 
SMAs and enhance patient-
experience 
Weaknesses: Small number of 
studies limited by inclusion criteria, 
single-center facilities may limit 
generalizability  
Conclusions: Standardized training 
and implementation of SMA’s is 
needed to ensure the most impactful 
outcomes. 
Recommendations: Results will be 
integrated into project to support 
importance of developing a 
standardized approach for a SMA 
curriculum on opioid safety  
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Appendix B 
VA Proactive Health and Well-Being Model 
 
Note: The Circle of Health is a visual picture of the Whole Health approach to care. This helps 
you explore connections between important aspects of your life and your health and well-being. 
(Simmons, Drake, Gaudet, & Snyderman, 2016). 
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Appendix C 
Team Composition Table 
 Team I Team II Team III 
Who was 
involved? 
Full PACT Staff Full PACT Staff 
Provider 
only 





Yes No No 
Education 
Delivery 
Handouts, Audiovisual, Classroom Instruction 
with Coaching 
Handouts, Audiovisual, Classroom Instruction Verbal 
Time Frame 
90 minutes every week for 9 Weeks to include 
health coaching (60 min.) starting Week 3 




Structured around the Whole Health Wheel 
Session 1: Introduction to Whole health & 
Opioid Safety 
 
Session 2: Working the Body 
Opioid Safety: Overdose Prevention 
(Naloxone) 
 
Session 3: Surroundings 
Opioid Safety: Taking Opioids Responsibly 
Coaching Session 
 
Session 4: Personal Development  
Opioid Safety: Side Effects & Risk 
Coaching Session 
 
Session 5: Food & Drink 
Opioid Safety: Pain Care Plan 
Coaching Session 
 
Session 6: Recharge & Sleep 




Session 7: Relationships 
Opioid Safety: Alternatives  
Coaching Session 
 
Session 8: Spirit & Soul 
Opioid Safety: Opioid Tapering 
Coaching Session 
 
Session 9: Power of the Mind Relaxing & 
Healing 
Opioid Safety: Storage & Disposal 
Coaching Session 
 
Session 10: Full Circle Review 
Structured around the Whole Health 
Wheel 
Session 1: Introduction to Whole health & 
Opioid Safety 
 
Session 2: Working the Body 
Opioid Safety: Overdose Prevention 
(Naloxone) 
 
Session 3: Surroundings 
Opioid Safety: Taking Opioids Responsibly 
 
Session 4: Personal Development  
Opioid Safety: Side Effects & Risk 
 
Session 5: Food & Drink 
Opioid Safety: Pain Care Plan 
 
Session 6: Recharge & Sleep 
Opioid Safety: Withdrawal, Dependence, 
Disorder 
 
Session 7: Relationships 
Opioid Safety: Alternatives  
 
Session 8: Spirit & Soul 
Opioid Safety: Opioid Tapering  
 
Session 9: Power of the Mind Relaxing & 
Healing 
Opioid Safety: Storage & Disposal 
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Appendix E  
Gap Analysis 
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Appendix F  
Gantt Chart 
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Appendix G 
Work Breakdown Structure 
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Appendix I 
Project Budget: Costs Associated with 90-Minute, Nine Session SMA 
 
Retroactive Chart Review By RN 
90 pts = 30 min 
$3,375.00 
Printing Paper (2) $8.00 
Plastic Binders (15)  $45.00 







TOTAL COST: $13,382.00 
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Appendix J 
Responsibility / Communication Matrix 
Communication Frequency Goal Route 
Academic Advisors  
Dr. Knighten Weekly Review project status, discuss 
barriers and updates, share 
progress 
Email, zoom, phone 
calls 
Co-Chair/Second Reader As needed To received feedback from 
draft prospectus  
Email, zoom if 
necessary 
Project Sponsors  
Executive Leadership Team 
(to include the Director, Chief 
of Staff, Chief Nurse 
Executive) 
Monthly Review project status, request 
support as needed 
Face-to-face, Emails 




Review Project from clinical 
perspective strategize about 




Dr. Huie (Director, Primary 
Care) 
Monthly Review Project from a Primary 
Care perspective, strategize 




Site (Birmingham VA Medical Center) 
Dr. R. Moore (Mentor) Bi-
Monthly 
Discuss data collection 
methodology and analysis plan 
Face-to-face 
Dr. B. Roop (PharmD) Monthly Review project status Face-to-face 
Project Site Nurse Educator 
J. Falkner Twice a 
week 
Discuss development and 
launching of patient 
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Appendix K  
Cost-Benefit Analysis 
Opioid Safety SMA Program Year 1 Year 2 Year 3 
SALARY COST    
Medical Doctor (MD)  
 
$     1,848.00  
 
$     1,884.96  
 
$    1,922.66  
Pharmacist (PharmD)  
 
$     1,020.00  
 
$     1,040.40  
 
$    1,061.21  
Registered Nurse (RN) 
 
$        540.00  
 
$        550.80  
 
$       561.82  
Licensed Practical Nurse (LPN)  
 
$        372.00  
 
$        379.44  
 
$        387.03  
Medical Service Assistant (MSA)  
 
$        324.00  
 
$        330.48  
 
$        337.09  
Other Cost    
Training 
 
$     5,496.00  
 
$     6,008.82  
 
$     6,129.00  
Supplies 
 
$         53.00  
 
$          54.06  
 
$         55.14  
Cumulative Cost 
 
$    9,653.00  
 
$   10,248.96  
 
$ 10,453.94  
Benefit/Cost Avoidance    
Cost avoidance from primary care office visit 
 
$ 60,000.00  
 
$   61,200.00  
 
$ 62,224.00 
    
Cumulative Cost/Benefit 
 
$ 50,347.00  
 
$   50,951.04  
 
$ 51,970.06  
    
Assumptions    
2% Cost of living adjustment annually    
2% Annual Increase in Training/Supply Costs    
Equal number of patients in SMA and Office groups   
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Appendix L 
 CQI Method 
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Appendix M 
 Patient Report Outcomes Measurement Instrument 
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Appendix N 
My Health Report Card 
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Appendix O 
Data Collection Tool 
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Appendix P 
USF Statement of Determination  
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Appendix Q 
 Signed Statement of Non-Research Determination Form 
Student Name: Sherry L. Cox 
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Letter of Support 
 
 




 Implementation Guide Index 
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 Program Flyer 
 
 
A WHOLE HEALTH APPROACH FOR REDUCING 
OPIOID RELIANCE
What is Whole Health?
Whole Health is an approach centered around what matters to you, not what is the matter with you. It 
uses group sessions to introduce self-care techniques like mindfulness and yoga. These techniques help 
you take charge of your health and well-being and live life to the fullest.
How Will This Help Me?
The Whole Health System Model includes key 
elements that focus on:
Me: It begins with you, the “Me” at the 
center. Your story is unique and your 
whole health begins with what matters 
to you
Self Care: You have the power to 
impact your well-being. Whole Health 
provides the support you need to 
make the changes you want
Professional Care: Your health care 
team is here to help
Community: Friends, family, and others 
who support you on your journey 
ct
WANT TO KNOW 
MORE?
